Abans Enterprises Intrinsic Value
Abans Enterprises (ABANSENT) median intrinsic value is ₹65.17 from 4 valuation models (range ₹52–₹65), vs current price ₹26.07 — +150.0% upside (Trading Below Calculated Value), margin of safety 60.0%. Check ABANSENT company valuation to track the company's total market size over time.
ABANSENT Valuation Methods Summary — DCF, Graham Number & P/E
Abans Enterprises intrinsic value across 4 models vs current price ₹26.07 — upside/downside and value range per method. See ABANSENT price book multiple to compare market price against book value per share.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹65.17 | ₹58.65 - ₹71.69 | +150.0% | Book Value/Share: ₹154.29, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹52.14 | ₹46.93 - ₹57.35 | +100.0% | Revenue/Share: ₹18637.14, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹52.14 | ₹46.93 - ₹57.35 | +100.0% | EBITDA: ₹44.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹65.17 | ₹52.14 - ₹78.20 | +150.0% | CF Growth: 15.0%, Discount: 15% |
ABANSENT Intrinsic Value vs Market Price — All Valuation Models
Abans Enterprises fair value range ₹52–₹65 vs current market price ₹26.07 across 4 valuation models. For current market price and key ratios, visit Abans Enterprises share price chart.
ABANSENT Intrinsic Value Analysis — Undervalued or Overvalued?
Abans Enterprises median intrinsic value ₹65.17, current price ₹26.07 — Trading Below Calculated Value by 150.0%, margin of safety 60.0%.
What is the intrinsic value of ABANSENT?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Abans Enterprises (ABANSENT) is ₹65.17 (median value). With the current market price of ₹26.07, this represents a +150.0% variance from our estimated fair value.
The valuation range spans from ₹52.14 to ₹65.17, indicating ₹52.14 - ₹65.17.
Is ABANSENT undervalued or overvalued?
Based on our multi-method analysis, Abans Enterprises (ABANSENT) appears to be trading below calculated value by approximately 150.0%.
ABANSENT Financial Health — Key Ratios vs Industry Benchmarks
Abans Enterprises financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 12.79 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -14.8% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Asset Turnover Ratio | 66.56x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
ABANSENT Cash Flow Quality — Operating & Free Cash Flow
Abans Enterprises operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹161 Cr | ₹138 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹-193 Cr | ₹-193 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹59 Cr | ₹4 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹-25 Cr | ₹-25 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹63 Cr | ₹42 Cr | Positive Free Cash Flow | 8/10 |